News Search

Tag: External Stories

Penn Spinout Verismo Therapeutics Creates New R&D Facility in CIC on Market St

Verismo plans to use this space for its in-house translational research.

Penn Spinout Avisi Technologies Raises $4.06 Million in Seed Round To Be Used to Develop Glaucoma Treatment Device

Avisi was founded in 2017 by Penn students Rui Jing J., the company's CEO, and Brandon Kao and Adarsh Battu, who were studying business and engineering.

I-Corps Participant and Vetigenics Founder Nicola Mason Featured on CBS 60 Minutes for Canine Cancer Research

Nicola Mason, BVetMed, PhD, of Penn Vet was featured on CBS' 60 Minutes, where she spoke about her research on immunotherapy treatment for cancer in dogs.

Penn Today Interviews John Swartley About PCI’s Impact

In the article, Swartley discusses some key highlights from FY22, including the major impact Penn technologies have made on patients.

Pennovation Works Welcomes New Director Denita Henderson

Henderson, Penn alumna and Philly native, will spearhead the implementation of Pennovation’s long-range strategic plan, including development of the site, marketing, communications and leasing.

Penn Dental Medicine Study Finds That Cavity-causing Microbes Have the Ability to Form Superorgranisms that Can Crawl on Teeth

A Penn Dental Medicine study found that cavity-causing microbes have the ability to form superorgranisms that can sprout “limbs” that propel them to“leap” to quickly spread on the tooth surfaces.

Penn spinout Neuralert Technologies’ stroke detection wristband selected for TIME’s List of the Best Inventions of 2022

The lightweight, non-invasive wristband device can detect the stroke symptoms in as little as 15 minutes.

Emily Whitehead’s CAR-T Cell Therapy Journey Featured on CBS

CBS This Morning recently featured a story about Emily Whitehead, the first pediatric patient to receive Penn-invented CAR T cell therapy to fight cancer.

PCI Ventures @ Pennovation Works Showcase Shines Spotlight on Penn-Affiliated Startups Making a Difference

PCI Ventures, a division of PCI specifically focused on creating early-stage businesses founded on Penn technology, recently held a showcase at Pennovation Works.

Drew Weismann Speaks on the Future of mRNA Technology in Bloomberg’s “The Big Take” Podcast

Weissman talks about his discovery and the impact of mRNA technology on the development of therapies for flu, cancer and rare genetic diseases.


Skip to content